VolitionRx Limited Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- VolitionRx Limited treasury stock, value, acquired, cost method for the quarter ending 2021-03-31 was $0.00.
- VolitionRx Limited treasury stock, value, acquired, cost method for the quarter ending 2020-12-31 was $0.00.
- VolitionRx Limited treasury stock, value, acquired, cost method for the quarter ending 2020-09-30 was $0.00.
- VolitionRx Limited treasury stock, value, acquired, cost method for the quarter ending 2020-06-30 was $0.00.
- VolitionRx Limited treasury stock, value, acquired, cost method for fiscal 2020 was -$54.43K.
- VolitionRx Limited treasury stock, value, acquired, cost method for fiscal 2019 was $0.00.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-11 | $0.00 derived: sum of 4 quarters · filed 2021-05-11 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | -$54.43K 10-K · filed 2021-03-22 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$54.43K derived: sum of 4 quarters · filed 2021-05-11 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$54.43K derived: sum of 4 quarters · filed 2021-05-11 |
| 2020-03-31 | -$54.43K 10-Q · filed 2021-05-11 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $0.00 10-K · filed 2021-03-22 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |